73 | PRIMARY ENDPOINT EVALUATION OF A MULTICENTER PHASE 2 STUDY OF VENETOCLAX IN COMBINATION WITH R‐CHOP (VR‐CHOP) FOR PATIENTS WITH RICHTER SYNDROME

Matthew S. Davids, Kathleen A. Rogers, Jennifer R. Brown et al.|Hematological Oncology|2025

Cited by 0